SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-20-001072
Filing Date
2020-02-27
Accepted
2020-02-27 06:24:58
Documents
84
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2240828z10-k.htm 10-K 1418694
2 EX-4.3 a2240828zex-4_3.htm EX-4.3 34176
3 EX-23.1 a2240828zex-23_1.htm EX-23.1 2938
4 EX-31.1 a2240828zex-31_1.htm EX-31.1 7921
5 EX-31.2 a2240828zex-31_2.htm EX-31.2 7944
6 EX-32.1 a2240828zex-32_1.htm EX-32.1 5053
13 G631132.JPG g631132.jpg GRAPHIC 16926
14 G128310.JPG g128310.jpg GRAPHIC 74873
15 G131806.JPG g131806.jpg GRAPHIC 104121
16 G463478.JPG g463478.jpg GRAPHIC 37838
  Complete submission text file 0001047469-20-001072.txt   6848733

Data Files

Seq Description Document Type Size
7 EX-101.INS rarx-20191231.xml EX-101.INS 1394565
8 EX-101.SCH rarx-20191231.xsd EX-101.SCH 54539
9 EX-101.CAL rarx-20191231_cal.xml EX-101.CAL 57055
10 EX-101.DEF rarx-20191231_def.xml EX-101.DEF 176394
11 EX-101.LAB rarx-20191231_lab.xml EX-101.LAB 506349
12 EX-101.PRE rarx-20191231_pre.xml EX-101.PRE 366505
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37926 | Film No.: 20658380
SIC: 2834 Pharmaceutical Preparations